OBJECTIVES: Anatomical lobar resection and mediastinal lymphadenectomy remain the standard for the treatment of early stage non-small-cell lung cancer (NSCLC) and are preferred over procedures such as segmentectomy or wedge resection. However, there is an ongoing debate concerning the influence of the extent of the resection on overall survival. The aim of this article was to assess the overall survival for different types of resection for Stage I NSCLC.
INTRODUCTION
Anatomical lobar resection and mediastinal lymphadenectomy remain the standard in the treatment of early stage non-smallcell lung cancer (NSCLC) and are preferred over other operations such as segmentectomy or wedge resection [1] . Given the current knowledge and according to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines regarding sublobar resection, segmentectomy or wedge resection is appropriate for patients with insufficient pulmonary reserve or with other major comorbidities, as well as for patients with a tumour smaller than 2 cm with 1 of the following features: pure adenocarcinoma in situ confirmed by histopathological analysis, ground-glass appearance of more than half the nodule on computed tomography (CT), or slow, indolent growth observed during CT surveillance, with a volume doubling time longer than 400 days [2] .
The aim of the article was to assess the influence of the extent of resection on overall survival and early postoperative deaths among Stage I NSCLC patients who underwent routine wedge resection, segmentectomy or lobectomy based on data from the Polish National Lung Cancer Registry (PNLCR).
MATERIALS AND METHODS

Study group
We performed a retrospective analysis of surgical treatment results of patients with Stage I NSCLC. Each of the 27 thoracic surgery departments in Poland obligatorily contributes lung cancer treatment data to the national database. Between 1 January 2007 and 31 December 2013, data from 16 446 patients who underwent resection for lung cancer were collected in the PNLCR. In this meticulously maintained database, surgical, clinical and pathological information as well as follow-up data on patients treated for lung cancer is recorded and used for further analysis.
Patients with lung cancer were classified according to the 7th edition of the TNM Classification for Lung Cancer [3] and the 2004 World Health Organization (WHO) Classification Tumours of the Lung, Pleura, Thymus and Heart [4] .
The following features served as exclusion criteria: resections preserving lung parenchyma (bronchial and tracheal sleeve resections), pneumonectomy, inconsistent data, lack of pathology report or Stage II-IV according to the 7th TNM classification. Six thousand nine hundred and five patients with pathology reports of Stage I lung cancer according to the 7th TNM classification who underwent lobectomy, anatomical segmentectomy or wedge resection were included in the study. The overall survival (OS) and the 30-and 90-day mortality rates were assessed for the patients in each study group with follow-up information from the national registry data.
Subsequently, to reduce the potential bias, a propensity score matching (PSM) analysis was used. Using the nearest neighbour matching method, 693 individuals were assigned to 1 of 3 groups according to the extent of resection: lobectomy, segmentectomy or wedge resection. The flow chart illustrating the eligibility process is detailed in Fig. 1 .
Statistical methods
The statistical analyses were conducted using MATLAB R2016a (MathWorks, Inc., Natick, MA, USA). The univariate association of each covariate with the extent of surgical resection was assessed using the chi-square test for nominal covariates, the KruskalWallis test with the Nemenyi post hoc test for ordinal covariates, and the analysis of variance with the Games-Howell post hoc test for interval covariates. Kaplan-Meier curves were generated to provide estimates for OS. Median follow-up time was calculated using a reverse Kaplan-Meier analysis. The association of the extent of surgical resection with OS was estimated using the Cox proportional hazards model. A power analysis of the Cox regression on unmatched samples was performed based on the null hypothesis that the hazard ratio (HR) was equal to 1 [5] . A propensity score matching method was implemented to reduce the treatment selection bias in the study sample. A nominal logistic regression model that predicted the extent of surgical resection was used to calculate the propensity scores including the following covariates: age, sex, histology, grade and date of resection. Cases from the 3 surgical resection groups were matched based on the propensity scores using a nearest neighbour with a calliper algorithm without replacement [6] . A difference of less than 0.2 times the standard deviation of the propensity scores was used to choose the calliper for matching. For the analysis of the propensity score, matched data tests that assumed the paired nature of the data were used [7] . To compare the Kaplan-Meier survival curves, a stratified log-rank test was used. To regress survival time on the different extents of surgical resection, a Cox proportional hazards model stratified on the matched pairs was used [8] . All statistical tests were two-sided with a 0.05 level of significance.
RESULTS
Unmatched population
Six thousand nine hundred and five patients met the eligibility criteria, with a median age of 63.3 years (interquartile range: 57.6-70.1). There were 2865 women and 4040 men. The mean tumour diameter was 20 mm (interquartile range: 15-26). Five hundred and ninety-six patients (8.6%) underwent resection via video-assisted thoracoscopic surgery. The mean number of resected lymph nodes was 8.3 (lobectomy), 5.2 (segmentectomy) and 2.1 (wedge resection). The reverse Kaplan-Meier estimate of median follow-up time after resection was 36.9 months (95% CI: 36.1-37.9%). All characteristics of the unadjusted patient groups are presented in Table 1 .
Based on the Kaplan-Meier analysis, the estimated 3-year and 5-year survival rates of the unmatched patients at TNM Stage I were 82.3% (95% CI: 81.2-83.3%) and 76.6% (95% CI: 75.4-78%), respectively. Based on the 95% confidence intervals, there was no difference in the 3-year and 5-year survival rates of patients after lobectomy (84.2%; 95% CI: 83.1-85.3% and 79.1%; 95% CI: 77.7-80.4%, respectively) or segmentectomy (80.0%; 95% CI: 72.9-87.1% and 78.3%; 95% CI: 70.6-86.0%, respectively). Wedge resection was associated with significantly lower 3-year (68.3%; 95% CI: 64.6-72.0%) and 5-year survival rates (58.1%; 95% CI: 53.6-62.5%) compared to lobectomy and segmentectomy. The estimated survival curves after lobectomy, segmentectomy and wedge resection are presented in Fig. 2 and are summarized in Table 2 . Based on results from the log-rank test, a significant difference in OS was observed between the unmatched patient groups (P < 0.001).
Based on the Cox proportional hazards model of the unmatched samples (Table 3) , no advantage of lobectomy over segmentectomy was observed with a HR equal to 1.23 (95% CI: 0.86-1.75). The HR for segmentectomy and lobectomy compared to wedge resection was significantly lower at 0.54 (95% CI: 0.37-0.77) and 0.44 (95% CI: 0.38-0.50), respectively. The results obtained suggest a significant advantage of segmentectomy and lobectomy over wedge resection. A power analysis performed based on the null hypothesis that the HR was equal to 1 proved that the study was not underpowered (Table 3) .
After assessing the influence of the tumour size on survival, we observed no significant differences in the 5-year survival rates between lobectomy and segmentectomy in the TNM Stage IA and IB patient groups. Moreover, we found no differences in survival between IA and IB patients who underwent segmentectomy. There was a significant difference between Stage IA and IB in the lobectomy and wedge resection patient groups (P < 0.001 and P = 0.001, respectively). An analysis assessing the influence of tumour size is presented in Table 4 . When we performed a Cox regression for patients with Stage IB tumours in the unmatched population, we obtained an HR that was smaller in comparison to lobectomy and segmentectomy [HR = 1.18 (0.58-2.38), P = 0.641] than the HR for all tumour sizes. This finding might suggest that for larger tumours, the potential advantage of lobectomy over segmentectomy decreases. As well, the HR for segmentectomy versus wedge resection was smaller [HR = 0.44 (0.21 -0.91), P = 0.028] than the HR for all tumour sizes, suggesting that for larger tumours, the advantage of segmentectomy over wedge resection increases. Overall, the 30-day and 90-day deaths in the TNM Stage I patient groups were 1.6% and 2.4%, respectively. No differences were observed between the 30-and 90-day deaths among the different groups of resections (Table 5 ).
Matched population
A propensity score-matched analysis was used to reduce the selection bias. Cases from the 3 surgical resection groups were selected using the following covariates: age, sex, histology, grade and date of resection. Six hundred and ninety-three individuals were assigned to 3 groups according to the extent of resection: lobectomy, segmentectomy or wedge resection.
Based on the Kaplan-Meier analysis, the estimated 3-year and 5-year survival rates of the matched patients were 79.2% (95% CI: 75.6-82.9%) and 70.2% (95% CI: 64.6-75.8%), respectively. No significant statistical difference was observed in the estimated 3-year and 5-year survival rates between the lobectomy (85.8%; 95% CI: 80.4-91.1% and 78.1%; 95% CI: 71.8-84.4%, respectively) and the segmentectomy groups (79.8%; 95% CI: 72.6-87.0% and 79.2%; 95% CI: 71.6-86.8%, respectively).
The estimated 5-year survival rate was significantly higher after lobectomy and segmentectomy than after wedge resection (54.0%; 95% CI: 40.8-67.3%). Wedge resection was associated with significantly lower 3-year survival rates (70.0%; 95% CI: 63.0-76.9%) compared to lobectomy. There was no statistical difference in 3-year survival rates when segmentectomy (79.8%; 95% CI: 72.6-87.0%) and wedge resection (70.0%; 95% CI: 63.0-76.9%) were compared. The estimated Kaplan-Meier survival curves after lobectomy, segmentectomy and wedge resection in the matched population are presented in Fig. 3 and summarized in Table 2 . Based on the stratified log-rank test, a significant difference in OS between the matched groups of patients was observed (P = 0.001).
Following a Cox proportional hazards model stratified on matched samples (Table 3) , the HR comparing lobectomy and segmentectomy was 1.65 (95% CI: 0.94-2.91), which suggested that there was no statistically significant benefit of lobectomy over segmentectomy. The HR for lobectomy compared to wedge resection was significantly lower and equal to 0.40 (95% CI: 0.24-0.66), suggesting a significant advantage of lobectomy over wedge resection. The HR for segmentectomy compared to wedge resection was lower (0.67; 95% CI: 0.41-1.08), but the advantage of segmentectomy over wedge Figure 2 : Kaplan-Meier survival curves based on the extent of pulmonary resection of the unadjusted population. The + sign indicates censored data. The light grey area around the survival curves indicates 95% confidence intervals. The P-value of the difference between 3 curves, estimated using the log-rank test, is shown in the lower corner. resection was not significant at the 0.05 level after population matching (P = 0.101).
DISCUSSION
Detailed medical data from all patients with NSCLC operated on in Poland are submitted to the PNLCR. Data submission to the PNLCR is mandatory and is organized and financed by the National Ministry of Health. All curative NSCLC procedures in Poland are performed exclusively by thoracic surgeons and are localized in 27 thoracic surgery departments. The PNLCR includes every patient operated on in Poland from 2007 until the present. Follow-up data regarding survival is continuously reported via the national registries. This organization of NSCLC treatment supports the high-quality procedures performed by adequately trained and devoted professionals. Anatomical resection with lymphadenectomy, according to the standards of the European Society of Thoracic Surgeons, is performed in each patient with NSCLC [9, 10] . Continuous reporting of the high volume of results to the national database allows the analysis of consecutive patients and is a valuable tool for both straightforward and propensity matched analysis. High-volume database studies tend to add new arguments to the ongoing discussion about the role of sublobar resections for the treatment of NSCLC. The landmark study was a prospective, randomized, multi-centre trial conducted more than 21 years ago. The study, summarized by Ginsberg et al. [11] on behalf of the Lung Cancer Study Group, reported unfavourable oncological results following sublobar resection compared to lobectomy in the treatment of Stage I NSCLC. This trial revealed a decreased risk of local recurrence and cancer-related death in patients with Stage I NSCLC who underwent lobectomy, which justified the position that lobectomy was the standard surgical treatment for NSCLC. Traditionally, segmentectomy and wedge resection are only potential alternatives in the treatment of patients with significant concomitant diseases and with diminished lung function. However, in our study, we found a significantly improved 5-year survival rate after lobectomy (79%) compared to wedge resection (58%). The 5-year survival rate after segmentectomy was comparable to that after lobectomy (78%); these findings were confirmed by the PSM analysis.
Since the time of the Ginsberg et al. study, due to advances in preoperative staging protocols, the minimally invasive operative techniques and perioperative care programs of many retrospective studies have been released. These studies compared lobectomy with segmentectomy and eventually with wedge resection but concluded that no differences existed in survival between the aforementioned resections [12] [13] [14] [15] . Contrary to Ginsberg et al., the patients in these studies were radiologically staged preoperatively with at least CT. Similarly, in the population of patients detected in the low-dose CT screening program, an excellent 10-year survival rate as high as 85% was reported after both lobectomy and segmentectomy [16] . These findings were confirmed by the 78-80% 5-year survival rate that we found, which was similar in the lobectomy and segmentectomy groups in patients with tumours smaller than 20 mm. On the contrary, previously published large database studies have reported better overall and cancer-specific survival after lobectomy compared to segmentectomy regardless of tumour size [17] . Even though segmentectomy traditionally was assumed to offer better oncological results than wedge excision, there is currently no unequivocal proof to support this statement. Altorki et al. [18] , in a retrospective study of patients with significant comorbidities, found similar 5-year survival and local recurrence rates in carefully staged groups of patients who underwent segmentectomy and lobectomy. Our study clearly shows that the patients who underwent wedge excision have poorer survival rates. This finding was confirmed both by direct analysis and partially by the PSM.
Whether lobectomy is superior to limited resections is difficult to determine using non-randomized studies because of the heterogeneity of the composite comorbidities of the patients accepted for lesser resections. This difficulty is exacerbated by the initial perioperative results observed in our study. The 30-and 90-day deaths in the segmentectomy group were higher than in the lobectomy group, which can be attributed to the heterogeneous population of poor surgical candidates, leading to less predictable postoperative complications. However, in the PSM analysis, the lobectomy and segmentectomy groups did not differ in relation to OS.
Recently, 3 meta-analyses on the topic were published by Nakamura et al. [19] , Fan et al. [20] and Bao et al. [21] . Bao et al. [21] reported that for tumours larger than 2 cm but smaller than 3 cm, lobectomy is indicated due to better overall and cancerspecific survival rates. For tumours 2 cm or less, segmentectomy provided equivalent outcomes compared to lobectomy.
The major limitation of this study is its retrospective nature. Nevertheless, a large number of patients (6905) from a wellmanaged national database were evaluated, which allowed us to draw conclusions based on a relatively high level of confidence. The carefully chosen data and well-matched sets of patients analysed by PSM confirmed the observations from the consecutive cohorts. In addition, a significant number of patients (especially before 2010) were not staged using positron emission tomography and data confirming the radiological staging are not included in the database. In this analysis, we did not include detailed information about the lymphadenectomy because we concentrated on the extent of pulmonary resection only. In this analysis, we also did not include data regarding concomitant diseases or preoperative pulmonary function tests, which could cause some biases in the interpretation of the results.
Finally, based on a large number of patients gathered in the national database, we concluded that segmentectomy, but not a wedge resection, could be considered an alternative to lobectomy in the treatment of Stage I NSCLC.
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